Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

290 та иш

Иш: Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

  1. Therapeutic peptides: current applications and future directions

    Lei Wang, Nanxi Wang, Wenping Zhang +6

    Шарҳ мақола20225 иқтибос
    ABI

  2. Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems

    Azeez Yusuf, Awatif Rashed Z. Almotairy, Hanan A. Henidi +2

    Шарҳ мақола20234 иқтибос
    ABI

  3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

    Steven P. Marso, Stephen C. Bain, Agostino Consoli +12

    Бошқа20163 иқтибос
    ABI

  4. Polymer-Based Hydrogels Applied in Drug Delivery: An Overview

    Hoc Thang Nguyen, Truong Bach Chien, Đặng Xuân Cường

    Шарҳ мақола20233 иқтибос
    ABI

  5. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

    Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen +5

    Шарҳ мақола20253 иқтибос
    ABI

  6. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

    Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12

    Мақола20162 иқтибос
    ABI

  7. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

    Мақола20192 иқтибос
    ABI

  8. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

    Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías +7

    Мақола20232 иқтибос
    ABI

  9. The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist

    Yun Kyung Cho, Yoo La Lee, Chang Hee Jung

    Шарҳ мақола20232 иқтибос
    ABI

  10. Designing hydrogels for controlled drug delivery

    Jianyu Li, David Mooney

    Шарҳ мақола20162 иқтибос
    ABI

  11. Tirzepatide Once Weekly for the Treatment of Obesity

    Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad +8

    Мақола20222 иқтибос
    ABI

  12. Alopecia and Semaglutide: Connecting the Dots for Patient Safety

    Diala Haykal

    Бошқа20252 иқтибос
    ABI

  13. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

    Ali Aminian, Abbas Al‐Kurd, Rickesha Wilson +13

    Мақола20212 иқтибос
    ABI

  14. Backbone N-methylation of peptides: Advances in synthesis and applications in pharmaceutical drug development

    Xuefei Li, Ningchao Wang, Yuhang Liu +4

    Шарҳ мақола20232 иқтибос
    ABI

  15. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021

    Masayuki Teramoto, Emmanuela Gakidou, Justin Lo +97

    Мақола20252 иқтибос
    ABI

  16. PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: Faster PEG shedding attenuates anti-PEG IgM production

    Takuya Suzuki, Yuta Suzuki, Taro Hihara +6

    Мақола20202 иқтибос
    ABI

  17. Incretin hormones: Their role in health and disease

    Michael A. Nauck, Juris J. Meier

    Шарҳ мақола20182 иқтибос
    ABI

  18. Translational Applications of Hydrogels

    Santiago Correa, Abigail K. Grosskopf, Hector Lopez Hernandez +4

    Шарҳ мақола20212 иқтибос
    ABI

  19. Hydrophilic Gels for Biological Use

    O. Wichterle, D. Lím

    Мақола19602 иқтибос
    ABI

  20. Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals

    János Szebeni

    Шарҳ мақола20142 иқтибос
    ABI

  21. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

    Christopher Sorli, Shin‐ichi Harashima, George Tsoukas +4

    Мақола20172 иқтибос
    ABI

  22. Regulation and function of the mammalian tricarboxylic acid cycle

    Paige K. Arnold, Lydia W.S. Finley

    Шарҳ мақола20222 иқтибос
    ABI

  23. Alveolarides: Antifungal Peptides from <i>Microascus alveolaris</i> Active against Phytopathogenic Fungi

    Serge Fotso, Paul R. Graupner, Quanbo Xiong +5

    Мақола20172 иқтибос
    ABI

  24. Trends in peptide drug discovery

    Markus Muttenthaler, Glenn F. King, David J. Adams +1

    Шарҳ мақола20212 иқтибос
    ABI

  25. Advances in Hydrogel-Based Drug Delivery Systems

    Boya Liu, Kuo Chen

    Мақола20242 иқтибос
    ABI